Empyrean will take up a new office space in the Half Moon Building at Lavitt’s Quay in Cork city.
Financial risk and performance management solutions provider to the banking industry Empyrean Solutions is to launch a new R&D project in Cork and create 40 new job opportunities.
Located at a new site at Lavitt’s Quay in Cork city and supported by the Government through IDA Ireland, the project will leverage advanced AI and machine learning techniques to deliver solutions that measure financial risk and provide insight into financial performance across several risk disciplines, including financial planning, credit loss estimation, loan behaviour analysis and finance persona-based insights, the company said.
Having launched in Ireland in 2018, Empyrean DC operates as the core R&D hub for Empyrean Solutions, leading multiple R&D projects and focusing on strategically scaling both team size and the number of software development projects running. The new office space is located in Cork’s Half Moon Building.
Commenting on the announcement, the CEO of IDA Ireland, Michael Lohan, said, “IDA Ireland is pleased to support Empyrean Solutions as it develops next-generation AI and machine learning capabilities in Cork. Projects like this strengthen Ireland’s position as a leading location for data-driven product development and financial services innovation.”
Paul Leahy, the managing director of Empyrean Ireland, said, “Empyrean is thrilled to embark on this R&D initiative with IDA Ireland. This project represents a significant step in our mission to empower the dynamic CFO.
“By combining advanced AI and machine learning with our financial risk and performance platform, we’re equipping finance leaders with the tools they need to operate with greater insight and confidence in an increasingly complex regulatory environment. We’re grateful for the support of IDA Ireland and the Irish Government as we build solutions that will make an impact for banks and credit unions.”
Earlier this month, Cork Airport Business Park announced plans to host the European headquarters of Evumed, a biopharmaceutical company that has committed to a multimillion-euro investment.
The move will see the creation of 30 new jobs at Evumed throughout 2026, in areas such as quality, regulatory, supply chain, finance and support functions.
Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.
You must be logged in to post a comment Login